Key facts
- This page summarizes David Soane's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2023, 21:11.
David Soane - 31 Jul 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 31 Jul 2023
- Net transaction value
- +$139,986
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2023, 21:11:28 UTC
- Prior SEC filing
- 06 Jan 2023
- Next SEC filing
- 12 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- David S. Soane (individually)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Soane filed Form 4 for Comera Life Sciences Holdings, Inc. on 02 Aug 2023.
Change
- Previous filing in this sequence was filed on 06 Jan 2023.
- Current net transaction value: +$139,986.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMRA
transaction
Common Stock
Purchase
- Transaction value
- $69,993
- Shares
- +136,919
- Change %
- +154%
- Price
- $0.5112
- Shares after
- 225,648
- Date
- 31 Jul 2023
- Ownership
- By Trust
- Footnotes
- F1, F2
CMRA
transaction
Common Stock
Purchase
- Transaction value
- $69,993
- Shares
- +136,919
- Change %
- +154%
- Price
- $0.5112
- Shares after
- 225,648
- Date
- 31 Jul 2023
- Ownership
- By Trust
- Footnotes
- F3, F4
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,336,562
- Date
- 31 Jul 2023
- Ownership
- By Trust
- Footnotes
- F5, F6
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 589,786
- Date
- 31 Jul 2023
- Ownership
- Direct
- Footnotes
- F7
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMRA
transaction
Derivative
Warrant (right to buy)
Purchase
- Transaction value
- $0
- Shares
- +342,298
- Change %
- Price
- $0.000000
- Shares after
- 342,298
- Date
- 31 Jul 2023
- Ownership
- By Trust
- Underlying class
- Common Stock
- Underlying amount
- 342,298
- Exercise price
- $0.6135
- Footnotes
- F2
CMRA
transaction
Derivative
Warrant (right to buy)
Purchase
- Transaction value
- $0
- Shares
- +342,298
- Change %
- Price
- $0.000000
- Shares after
- 342,298
- Date
- 31 Jul 2023
- Ownership
- By Trust
- Underlying class
- Common Stock
- Underlying amount
- 342,298
- Exercise price
- $0.6135
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Includes 4,298 Earn-Out Shares. Earn-Out Shares are shares of Common Stock held in escrow, which shares will be released if, at any time prior to May 19, 2024, either (i) the volume-weighted average price of the Common Stock is equal to or greater than $12.50 for twenty trading days within a thirty trading day period or (ii) upon a change of control with aggregate consideration in excess of $12.50 per share of Common Stock.
Footnote F2
Held by the Alexander V. Soane 2019 Irrevocable Trust. Members of David Soane's immediate family serve as trustee and are beneficiaries of such trusts. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
Footnote F3
Includes 4,298 Earn-Out Shares
Footnote F4
Held by the Nicholas V. Soane 2019 Irrevocable Trust. Members of David Soane's immediate family serve as trustee and are beneficiaries of such trusts. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
Footnote F5
Includes 663,288 Earn-Out Shares.
Footnote F6
Held by The Soane Family Trust, of which David Soane is a trustee and members of the Dr. Soane's immediate family are trustees and beneficiaries. Dr. Soane disclaims beneficial ownership except to the extent of his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
Footnote F7
Includes 119,779 Earn-Out Shares